Tuberculosis (TB), one of the oldest recorded human diseases, remains a major cause of death despite the use of vaccines and antibiotics. New vaccines and drugs are needed to combat the global TB epidemic. Understanding the genetics and physiology of *M. tuberculosis* and its interactions with the host is crucial for developing new treatments. This review summarizes the pathogenesis and molecular determinants of *M. tuberculosis* virulence, including the history of TB, clinical manifestations, and the role of host and bacterial responses. The review also discusses the genetic basis of *M. tuberculosis*, its virulence factors, and future research directions. TB has been present for thousands of years, with evidence of its existence in ancient populations. The origin of *M. tuberculosis* is debated, but it is believed to have evolved from soil-dwelling mycobacteria. The disease has been studied extensively, with historical records dating back to ancient times. TB has been a major cause of death in Europe and the New World, with mortality rates fluctuating over time due to factors such as public health measures, sanitation, and the emergence of drug-resistant strains. The disease is caused by *M. tuberculosis*, a bacterium that can survive in the host by evading immune responses and surviving within macrophages. The virulence of *M. tuberculosis* is determined by various factors, including its ability to survive in the host, evade immune responses, and cause disease. Animal models and macrophage studies are used to study the virulence of *M. tuberculosis* and its interactions with the host. The review also discusses the use of genetic and molecular approaches to identify virulence factors and develop new treatments for TB. The global TB crisis is exacerbated by the emergence of drug-resistant strains and the lack of effective vaccines and treatments in many parts of the world. The review highlights the importance of understanding the molecular mechanisms of *M. tuberculosis* virulence to develop new strategies for TB control.Tuberculosis (TB), one of the oldest recorded human diseases, remains a major cause of death despite the use of vaccines and antibiotics. New vaccines and drugs are needed to combat the global TB epidemic. Understanding the genetics and physiology of *M. tuberculosis* and its interactions with the host is crucial for developing new treatments. This review summarizes the pathogenesis and molecular determinants of *M. tuberculosis* virulence, including the history of TB, clinical manifestations, and the role of host and bacterial responses. The review also discusses the genetic basis of *M. tuberculosis*, its virulence factors, and future research directions. TB has been present for thousands of years, with evidence of its existence in ancient populations. The origin of *M. tuberculosis* is debated, but it is believed to have evolved from soil-dwelling mycobacteria. The disease has been studied extensively, with historical records dating back to ancient times. TB has been a major cause of death in Europe and the New World, with mortality rates fluctuating over time due to factors such as public health measures, sanitation, and the emergence of drug-resistant strains. The disease is caused by *M. tuberculosis*, a bacterium that can survive in the host by evading immune responses and surviving within macrophages. The virulence of *M. tuberculosis* is determined by various factors, including its ability to survive in the host, evade immune responses, and cause disease. Animal models and macrophage studies are used to study the virulence of *M. tuberculosis* and its interactions with the host. The review also discusses the use of genetic and molecular approaches to identify virulence factors and develop new treatments for TB. The global TB crisis is exacerbated by the emergence of drug-resistant strains and the lack of effective vaccines and treatments in many parts of the world. The review highlights the importance of understanding the molecular mechanisms of *M. tuberculosis* virulence to develop new strategies for TB control.